Amedeo Smart

Free Medical Literature Service

 

Amedeo

Influenza
  Free Subscription

Articles published in
Virus Res
    May 2024
  1. GLENET M, Lebreil AL, N'Guyen Y, Meyer I, et al
    Structural impact of a new spike Y170W mutation detected in early emerging SARS-CoV-2 Omicron variants in France.
    Virus Res. 2024;343:199354.
    >> Share

  2. KUZIKOV M, Reinshagen J, Wycisk K, Corona A, et al
    Drug repurposing screen to identify inhibitors of the RNA polymerase (nsp12) and helicase (nsp13) from SARS-CoV-2 replication and transcription complex.
    Virus Res. 2024;343:199356.
    >> Share

    April 2024
  3. LIU D, Leung KY, Lam HY, Zhang R, et al
    Interaction and antiviral treatment of coinfection between SARS-CoV-2 and influenza in vitro.
    Virus Res. 2024;345:199371.
    >> Share

  4. ZHANG S, Wang P, Shi L, Wang C, et al
    Exploring COVID-19 causal genes through disease-specific Cis-eQTLs.
    Virus Res. 2024;342:199341.
    >> Share

  5. MONTENEGRO AFL, Clementino MAF, Yaochite JNU
    Type I interferon pathway genetic variants in severe COVID-19.
    Virus Res. 2024;342:199339.
    >> Share

  6. LIM T, Rajoriya S, Kim B, Natasha A, et al
    In vitro broad-spectrum antiviral activity of MIT-001, a mitochondria-targeted reactive oxygen species scavenger, against severe acute respiratory syndrome coronavirus 2 and multiple zoonotic viruses.
    Virus Res. 2024;342:199325.
    >> Share

    March 2024
  7. JANSEN JM, Meineke R, Molle A, van de Sandt CE, et al
    Selective pressure mediated by influenza virus M1(58-66) epitope-specific CD8(+)T cells promotes accumulation of extra-epitopic amino acid substitutions associated with viral resistance to these T cells.
    Virus Res. 2024;343:199355.
    >> Share

  8. LARBI I, Marwa A, Souai O, Tougorti H, et al
    Phylogeographic Dynamics of H9N2 Avian Influenza Viruses in Tunisia.
    Virus Res. 2024 Mar 9:199348. doi: 10.1016/j.virusres.2024.199348.
    >> Share

  9. WANG X, Cheng J, Shen L, Chen M, et al
    Rab5c promotes RSV and ADV replication by autophagy in respiratory epithelial cells.
    Virus Res. 2024;341:199324.
    >> Share

  10. HUANG X, Kantonen J, Nowlan K, Nguyen NA, et al
    Mucosal-Associated Invariant T Cells are not susceptible in vitro to SARS-CoV-2 infection but accumulate into the lungs of COVID-19 patients.
    Virus Res. 2024;341:199315.
    >> Share

    February 2024
  11. LI ZA, Bajpai AK, Wang R, Liu Y, et al
    Systems Genetics of Influenza A Virus-infected Mice Identifies TRIM21 as a Critical Regulator of Pulmonary Innate Immune Response.
    Virus Res. 2024 Feb 6:199335. doi: 10.1016/j.virusres.2024.199335.
    >> Share

  12. CEBALLOS-GARZON A, Comtet-Marre S, Peyret P
    Applying targeted gene hybridization capture to viruses with a focus to SARS-CoV-2.
    Virus Res. 2024;340:199293.
    >> Share

  13. ZHANG DQ, Ma QH, Yang MC, Belyakova YY, et al
    Peroxide derivatives as SARS-CoV-2 entry inhibitors.
    Virus Res. 2024;340:199295.
    >> Share

  14. DE ALMEIDA MARQUES DP, Andrade LAF, Reis EVS, Clarindo FA, et al
    New anti-SARS-CoV-2 aminoadamantane compounds as antiviral candidates for the treatment of COVID-19.
    Virus Res. 2024;340:199291.
    >> Share

    January 2024
  15. KODSI IA, Rayes DE, Koweyes J, Khoury CA, et al
    Tracking SARS-CoV-2 variants during the 2023 flu season and beyond in Lebanon.
    Virus Res. 2024;339:199289.
    >> Share

  16. CHRIST W, Klingstrom J, Tynell J
    SARS-CoV-2 variant-specific differences in inhibiting the effects of the PKR-activated integrated stress response.
    Virus Res. 2024;339:199271.
    >> Share

  17. CAI Z, Bai H, Ren D, Xue B, et al
    Integrin alphavbeta1 facilitates ACE2-mediated entry of SARS-CoV-2.
    Virus Res. 2024;339:199251.
    >> Share

  18. ESSAIDI-LAZIOSI M, Perez-Rodriguez FJ, Alvarez C, Sattonnet-Roche P, et al
    Distinct phenotype of SARS-CoV-2 Omicron BA.1 in human primary cells but no increased host range in cell lines of putative mammalian reservoir species.
    Virus Res. 2024;339:199255.
    >> Share

    December 2023
  19. KRISTENSEN C, Larsen LE, Trebbien R, Jensen HE, et al
    The avian influenza A virus receptor SA-alpha2,3-Gal is expressed in the porcine nasal mucosa sustaining the pig as a mixing vessel for new influenza viruses.
    Virus Res. 2023 Dec 22:199304. doi: 10.1016/j.virusres.2023.199304.
    >> Share

  20. OTA K, Sakai H, Sasaki D, Mitsumoto-Kaseida F, et al
    Rapid increase in salivary IgA and broad recognition of spike protein following SARS-CoV-2 vaccination.
    Virus Res. 2023 Dec 4:199294. doi: 10.1016/j.virusres.2023.199294.
    >> Share

    November 2023
  21. LI X, Ye Z, Plant EP
    5' copyback defective viral genomes are major component in clinical and non-clinical influenza samples.
    Virus Res. 2023;339:199274.
    >> Share

    October 2023
  22. NEDAEI F, Esmaeili Rastaghi AR, Goodarzi E, Haji Mullah Asadullah H, et al
    Introduction and effect of natural selection analysis at common mutations of SARS-CoV-2 spike gene in Iran.
    Virus Res. 2023;336:199202.
    >> Share

  23. CAO J, Gu H, Zhang X, Yun H, et al
    Intranasal inoculation of female BALB/c mice with replication-deficient human adenovirus type 5 expressing SARS-CoV-2 nucleocapsid protein aggravates lung pathology upon re-encountering the antigen.
    Virus Res. 2023;335:199201.
    >> Share

    September 2023
  24. TAKAZAWA S, Kotaki T, Nakamura S, Utsubo C, et al
    Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities.
    Virus Res. 2023;334:199176.
    >> Share

  25. STINCARELLI MA, Quagliata M, Di Santo A, Pacini L, et al
    SARS-CoV-2 inhibitory activity of a short peptide derived from internal fusion peptide of S2 subunit of spike glycoprotein.
    Virus Res. 2023;334:199170.
    >> Share

  26. ANDRADE-MOLINA DA, Morey-Leon GA, Munoz-Mawyin KE, Cruz-Fatuly FF, et al
    First sequenced cases of Omicron BA.2 sublineage in Ecuador.
    Virus Res. 2023;334:199169.
    >> Share

  27. WANG Z, Pan Q, Ma L, Zhao J, et al
    Anthracyclines inhibit SARS-CoV-2 infection.
    Virus Res. 2023;334:199164.
    >> Share

  28. BERNAL KDE, Whitehurst CB
    Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients.
    Virus Res. 2023;334:199157.
    >> Share

  29. STRAKOVA P, Bednar P, Kotoucek J, Holoubek J, et al
    Antiviral activity of singlet oxygen-photogenerating perylene compounds against SARS-CoV-2: Interaction with the viral envelope and photodynamic virion inactivation.
    Virus Res. 2023;334:199158.
    >> Share

    August 2023
  30. LEE MM, Cho WK, Cha MH, Yim NH, et al
    The antiviral activity of Thuja orientalis folium against Influenza A virus.
    Virus Res. 2023 Aug 13:199199. doi: 10.1016/j.virusres.2023.199199.
    >> Share

  31. TAKAHASHI T, Akagawa M, Kimura R, Sada M, et al
    Molecular evolutionary analyses of the fusion protein gene in human respirovirus 1.
    Virus Res. 2023;333:199142.
    >> Share

  32. KO MK, Kim HW, Park SH, Park JH, et al
    The role of zinc sulfate in enhancing cellular and humoral immune responses to foot-and-mouth disease vaccine.
    Virus Res. 2023 Aug 1:199189. doi: 10.1016/j.virusres.2023.199189.
    >> Share

    July 2023
  33. MOEINI S, Mohebbi A, Farahmand B, Mehrbod P, et al
    Phylogenetic analysis and docking study of neuraminidase gene of influenza A/H1N1 viruses circulating in Iran from 2010 to 2019.
    Virus Res. 2023 Jul 23:199182. doi: 10.1016/j.virusres.2023.199182.
    >> Share

  34. PRINS MLM, Prins C, de Vries JJC, Visser LG, et al
    Establishing immunogenicity and safety of needle-free intradermal delivery by nanoporous ceramic skin patch of mRNA SARS-CoV-2 vaccine as a revaccination strategy in healthy volunteers.
    Virus Res. 2023 Jul 18:199175. doi: 10.1016/j.virusres.2023.199175.
    >> Share

  35. GORI SAVELLINI G, Anichini G, Cusi MG
    SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells.
    Virus Res. 2023;332:199134.
    >> Share

  36. LI J, Li X, Mao H, Huang C, et al
    SARS-CoV-2 omicron BA.1.1 is highly resistant to antibody neutralization of convalescent serum from the origin strain.
    Virus Res. 2023;332:199131.
    >> Share

    June 2023
  37. JITOBAOM K, Sirihongthong T, Boonarkart C, Phakaratsakul S, et al
    Human Schlafen 11 inhibits influenza A virus production.
    Virus Res. 2023;334:199162.
    >> Share

  38. TAI W, Zheng J, Zhang X, Shi J, et al
    MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection.
    Virus Res. 2023;334:199156.
    >> Share

    May 2023
  39. ROY A, Sarkar A, Nayak D, Das S, et al
    Ultradiluted SARS-CoV-2 Spike Protein mitigates hyperinflammation in lung via ferritin and MMP-9 regulation in BALB/c mice.
    Virus Res. 2023;329:199091.
    >> Share

    April 2023
  40. NIE Y, Mou L, Long Q, Deng D, et al
    SARS-CoV-2 ORF3a positively regulates NF-kappaB activity by enhancing IKKbeta-NEMO interaction.
    Virus Res. 2023;328:199086.
    >> Share

  41. CUI X, Wang Y, Zhai J, Xue M, et al
    Future trajectory of SARS-CoV-2: Constant spillover back and forth between humans and animals.
    Virus Res. 2023;328:199075.
    >> Share

  42. CASTILLO G, Mora-Diaz JC, Breuer M, Singh P, et al
    Molecular mechanisms of human coronavirus NL63 infection and replication.
    Virus Res. 2023;327:199078.
    >> Share

  43. KLESTOVA Z
    Possible spread of SARS-CoV-2 in domestic and wild animals and body temperature role.
    Virus Res. 2023;327:199066.
    >> Share

  44. TALUKDAR SN, Osan J, Ryan K, Grove B, et al
    RSV-induced expanded ciliated cells contribute to bronchial wall thickening.
    Virus Res. 2023;327:199060.
    >> Share

  45. ANDRES C, Del Cuerpo M, Rabella N, Pinana M, et al
    Detection of reassortant influenza B strains from 2004 to 2015 seasons in Barcelona (Catalonia, Spain) by whole genome sequencing.
    Virus Res. 2023 Apr 1:199089. doi: 10.1016/j.virusres.2023.199089.
    >> Share

    March 2023
  46. CHAPOLA H, de Bastiani MA, Duarte MM, Freitas MB, et al
    A comparative study of COVID-19 transcriptional signatures between clinical samples and preclinical cell models in the search for disease master regulators and drug repositioning candidates.
    Virus Res. 2023;326:199053.
    >> Share

  47. DARVISH M, Moosavi-Nejad Z, Siadat SOR, Fatemi F, et al
    Enhancing neutralizing antibodies against receptor binding domain of SARS-CoV-2 by a safe natural adjuvant system.
    Virus Res. 2023;326:199047.
    >> Share

    February 2023
  48. YATES PJ, Mehta N, Watson HA, Peppercorn AF, et al
    Lessons from resistance analysis in clinical trials of IV zanamivir.
    Virus Res. 2023;325:199039.
    >> Share

  49. GOYA S, Sosa E, Nabaes Jodar M, Torres C, et al
    Assessing the hidden diversity underlying consensus sequences of SARS-CoV-2 using VICOS, a novel bioinformatic pipeline for identification of mixed viral populations.
    Virus Res. 2023;325:199035.
    >> Share

    January 2023
  50. BRUNO A, Goni N, Cristina J
    Spatial, temporal and evolutionary insight into seasonal epidemic Influenza A virus strains near the equatorial line: The case of Ecuador.
    Virus Res. 2023;326:199051.
    >> Share

  51. JIN X, Liu X, Shen C
    A systemic review of T-cell epitopes defined from the proteome of SARS-CoV-2.
    Virus Res. 2023;324:199024.
    >> Share

    December 2022
  52. GALLI C, Pellegrinelli L, Giardina F, Ferrari G, et al
    On the lookout for influenza viruses in Italy during the 2021-2022 season: along came A(H3N2) viruses with a new phylogenetic makeup of their hemagglutinin.
    Virus Res. 2022 Dec 26:199033. doi: 10.1016/j.virusres.2022.199033.
    >> Share

  53. LIU YC, Liao GR, Tsai AY, Tseng CY, et al
    NS2 is a key determinant of compatibility in reassortant avian influenza virus with heterologous H7N9-derived NS segment.
    Virus Res. 2022 Dec 23:199028. doi: 10.1016/j.virusres.2022.199028.
    >> Share

  54. WANG Q, Zeng X, Tan S, Lan L, et al
    Pathogenicity and anti-infection immunity of animal H3N2 and H6N6 subtype influenza virus cross-species infection with tree shrews.
    Virus Res. 2022 Dec 18:199027. doi: 10.1016/j.virusres.2022.199027.
    >> Share

    November 2022
  55. RUANGRUNG K, Chakritbudsabong W, Thongon S, Rungarunlert S, et al
    Analysis of Influenza A virus infection in human induced pluripotent stem cells (hiPSCs) and their derivatives.
    Virus Res. 2022 Nov 19:199009. doi: 10.1016/j.virusres.2022.199009.
    >> Share

  56. SEMPLE SL, Alkie TN, Jenik K, Warner BM, et al
    More tools for our toolkit: The application of HEL-299 cells and dsRNA-nanoparticles to study human coronaviruses in vitro.
    Virus Res. 2022;321:198925.
    >> Share

  57. HU X, Cui J, Chen J, Du S, et al
    Identification of hACE2-interacting sites in SARS-CoV-2 spike receptor binding domain for antiviral drugs screening.
    Virus Res. 2022;321:198915.
    >> Share

  58. OLIVEIRA FADS, de Holanda MV, Lima LB, Dantas MB, et al
    Genomic surveillance: Circulating lineages and genomic variation of SARS-CoV-2 in early pandemic in Ceara state, Northeast Brazil.
    Virus Res. 2022;321:198908.
    >> Share

  59. DA SILVA MS, Gularte JS, Filippi M, Demoliner M, et al
    Genomic and epidemiologic surveillance of SARS-CoV-2 in Southern Brazil and identification of a new Omicron-L452R sublineage.
    Virus Res. 2022;321:198907.
    >> Share

  60. WANG B, Liu H
    Identification of potential immune/diagnosis related gene-immunocyte subtype networks in extracellular immune response to respiratory syncytial virus infection.
    Virus Res. 2022;321:198906.
    >> Share

    October 2022
  61. CHU JT, Gu H, Sun W, Fan RL, et al
    Heterosubtypic immune pressure accelerates emergence of influenza A virus escape phenotypes in mice.
    Virus Res. 2022 Oct 24:198991. doi: 10.1016/j.virusres.2022.198991.
    >> Share

  62. UPADHYAY M, Gupta S
    Endoplasmic reticulum secretory pathway: Potential target against SARS-CoV-2.
    Virus Res. 2022;320:198897.
    >> Share

  63. SOLOMON M, Liang C
    Human coronaviruses: The emergence of SARS-CoV-2 and management of COVID-19.
    Virus Res. 2022;319:198882.
    >> Share

  64. NAIDOO N, Moodley J, Khaliq OP, Naicker T, et al
    Neuropilin-1 in the pathogenesis of preeclampsia, HIV-1, and SARS-CoV-2 infection: A review.
    Virus Res. 2022;319:198880.
    >> Share

  65. GABER Y, Abdel Alem S, Musa S, Amer K, et al
    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulins using chemiluminescence immunoassay and its correlation with neutralizing antibodies.
    Virus Res. 2022;319:198852.
    >> Share

    September 2022
  66. LARBI I, Ghedira K, Marwa A, Butcher GD, et al
    Phylogenetic analysis and assessment of the pathogenic potential of the first H9N2 avian influenza viruses isolated from wild birds and lagoon water in Tunisia.
    Virus Res. 2022 Sep 17:198929. doi: 10.1016/j.virusres.2022.198929.
    >> Share

  67. HEIDER A, Wedde M, Durrwald R, Wolff T, et al
    Molecular characterization and evolution dynamics of influenza B viruses circulating in Germany from season 1996/1997 to 2019/2020.
    Virus Res. 2022 Sep 9:198926. doi: 10.1016/j.virusres.2022.198926.
    >> Share

  68. BHAT S, Rishi P, Chadha VD
    Understanding the epigenetic mechanisms in SARS CoV-2 infection and potential therapeutic approaches.
    Virus Res. 2022;318:198853.
    >> Share

  69. NUNES DBSM, Vieira C, Sa JM, Araujo GC, et al
    M2-2 gene as a new alternative molecular marker for phylogenetic, phylodynamic, and evolutionary studies of hRSV.
    Virus Res. 2022;318:198850.
    >> Share

  70. SHOKEEN K, Pandey S, Shah M, Kumar S, et al
    Insight towards the effect of the multi basic cleavage site of SARS-CoV-2 spike protein on cellular proteases.
    Virus Res. 2022;318:198845.
    >> Share

    August 2022
  71. SULTANKULOVA KT, Dzhekebekov KK, Orynbayev MB, Burashev YD, et al
    Evidence for flock transmission of individual subtypes and strains of avian influenza viruses: A monitoring study of wild birds in Kazakhstan.
    Virus Res. 2022 Aug 19:198898. doi: 10.1016/j.virusres.2022.198898.
    >> Share

  72. FAYAD N, Habib WA, El-Shesheny R, Kandeil A, et al
    Lebanese SARS-CoV-2 genomics: 24 months of the pandemic.
    Virus Res. 2022;317:198824.
    >> Share

    July 2022
  73. MEISTER TL, Gottsauner JM, Schmidt B, Heinen N, et al
    Mouthrinses against SARS-CoV-2 - High antiviral effectivity by membrane disruption in vitro translates to mild effects in a randomized placebo-controlled clinical trial.
    Virus Res. 2022;316:198791.
    >> Share

  74. ABDOLI M, Shafaati M, Ghamsari LK, Abdoli A, et al
    Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2.
    Virus Res. 2022 Jul 9:198857. doi: 10.1016/j.virusres.2022.198857.
    >> Share

  75. ALCANTARA LCJ, Nogueira E, Shuab G, Tosta S, et al
    SARS-CoV-2 epidemic in Brazil: how the displacement of variants has driven distinct epidemic waves.
    Virus Res. 2022;315:198785.
    >> Share

  76. DE AMARAL M, Ienes-Lima J
    Anurans against SARS-CoV-2: A review of the potential antiviral action of anurans cutaneous peptides.
    Virus Res. 2022;315:198769.
    >> Share

  77. GAIARSA S, Giardina F, Batisti Biffignandi G, Ferrari G, et al
    Comparative analysis of SARS-CoV-2 quasispecies in the upper and lower respiratory tract shows an ongoing evolution in the spike cleavage site.
    Virus Res. 2022;315:198786.
    >> Share

  78. SARKAR A, Paul S, Singh C, Chowdhury N, et al
    A novel plant lectin, NTL-125, interferes with SARS-CoV-2 interaction with hACE2.
    Virus Res. 2022;315:198768.
    >> Share

  79. BANSAL K, Kumar S
    Mutational cascade of SARS-CoV-2 leading to evolution and emergence of omicron variant.
    Virus Res. 2022;315:198765.
    >> Share

    June 2022
  80. PAZ M, Aldunate F, Arce R, Ferreiro I, et al
    An evolutionary insight into Severe Acute Respiratory Syndrome Coronavirus 2 Omicron variant of concern.
    Virus Res. 2022;314:198753.
    >> Share

    May 2022
  81. YANG F, Zhu L, Liu F, Cheng L, et al
    Generation and characterization of monoclonal antibodies against the hemagglutinin of H3N2 influenza A viruses.
    Virus Res. 2022 May 17:198815. doi: 10.1016/j.virusres.2022.198815.
    >> Share

  82. MAITI AK
    Evolutionary shift from purifying selection towards divergent selection of SARS-CoV2 favors its invasion into multiple human organs.
    Virus Res. 2022;313:198712.
    >> Share

    April 2022
  83. ALMEIDA F, Santos LA, Trigueiro-Louro JM, RebelodeAndrade H, et al
    Optimization of A(H1N1)pdm09 vaccine seed viruses: the source of PB1 and HA vRNA as a major determinant for antigen yield.
    Virus Res. 2022 Apr 30:198795. doi: 10.1016/j.virusres.2022.198795.
    >> Share

  84. WEI N, Wang Q, Lin Z, Xu L, et al
    Systematic profiling of antigen bias in humoral response against SARS-CoV-2.
    Virus Res. 2022;312:198711.
    >> Share

  85. KOBAYASHI D, Hiono T, Ichii O, Nishihara S, et al
    Turkeys possess div6erse Siaalpha2-3Gal glycans that facilitate their dual susceptibility to avian influenza viruses isolated from ducks and chickens.
    Virus Res. 2022 Apr 13:198771. doi: 10.1016/j.virusres.2022.198771.
    >> Share

  86. GULARTE JS, da Silva MS, Mosena ACS, Demoliner M, et al
    Early introduction, dispersal and evolution of Delta SARS-CoV-2 in Southern Brazil, late predominance of AY.99.2 and AY.101 related lineages.
    Virus Res. 2022;311:198702.
    >> Share

  87. MIYAOKA Y, Yamaguchi M, Kadota C, Hasan MA, et al
    Rapid in vitro virucidal activity of slightly acidic hypochlorous acid water toward aerosolized coronavirus in simulated human-dispersed droplets.
    Virus Res. 2022;311:198701.
    >> Share

    March 2022
  88. ARBI M, Larbi I, Nsiri J, Behi IE, et al
    Inhibition of avian influenza virus H9N2 infection by antiviral hexapeptides that target viral attachment to epithelial cells.
    Virus Res. 2022;313:198745.
    >> Share

  89. GERDOL M, Dishnica K, Giorgetti A
    Emergence of a recurrent insertion in the N-terminal domain of the SARS-CoV-2 spike glycoprotein.
    Virus Res. 2022;310:198674.
    >> Share

  90. MOHEBALI M, Hassanpour G, Zainali M, Gouya MM, et al
    SARS-CoV-2 in domestic cats (Felis catus) in the northwest of Iran: Evidence for SARS-CoV-2 circulating between human and cats.
    Virus Res. 2022;310:198673.
    >> Share

    February 2022
  91. DING XM, Wang YF, Lyu Y, Zou Y, et al
    The effect of influenza A (H1N1) pdm09 virus infection on cytokine production and gene expression in BV2 microglial cells.
    Virus Res. 2022 Feb 28:198716. doi: 10.1016/j.virusres.2022.198716.
    >> Share

    January 2022
  92. PERBOLIANACHIS P, Ferla D, Arce R, Ferreiro I, et al
    Phylogenetic analysis of SARS-CoV-2 viruses circulating in the South American region: genetic relations and vaccine strain match.
    Virus Res. 2022 Jan 21:198688. doi: 10.1016/j.virusres.2022.198688.
    >> Share

  93. SLAVOV SN, Bezerra RDS, Rodrigues ES, Santos EV, et al
    Genomic monitoring of the SARS-CoV-2 B1.1.7 (WHO VOC Alpha) in the Sao Paulo state, Brazil.
    Virus Res. 2022;308:198643.
    >> Share

  94. KUMAR S, Bansal K
    Cross-sectional genomic perspective of epidemic waves of SARS-CoV-2: A pan India study.
    Virus Res. 2022;308:198642.
    >> Share

  95. PAUL S, Bravo Vazquez LA, Reyes-Perez PR, Estrada-Meza C, et al
    The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review.
    Virus Res. 2022;308:198631.
    >> Share

  96. ALVAREZ-DIAZ DA, Laiton-Donato K, Torres-Garcia OA, Ruiz-Moreno HA, et al
    Reduced levels of convalescent neutralizing antibodies against SARS-CoV-2 B.1+L249S+E484K lineage.
    Virus Res. 2022;308:198629.
    >> Share

  97. PRATHIVIRAJ R, Chellapandi P, Begum A, Kiran GS, et al
    Identification of genotypic variants and its proteomic mutations of Brazilian SARS-CoV-2 isolates.
    Virus Res. 2022;307:198618.
    >> Share

    December 2021
  98. YANG F, Dong D, Wu D, Zhu L, et al
    A multiplex real-time RT-PCR method for detecting H5, H7 and H9 subtype avian influenza viruses in field and clinical samples.
    Virus Res. 2021;309:198669.
    >> Share

  99. NISHIOKA K, Daidoji T, Nakaya T
    Downregulation of calcium-regulated heat stable protein 1 expression by low-temperature stimulation causes reduction of interferon-beta expression and sensitivity to influenza viral infection.
    Virus Res. 2021;309:198659.
    >> Share

  100. PORTER WT, Kelley EJ, Bowers JR, Engelthaler DM, et al
    Normalization of SARS-CoV-2 viral load via RT-qPCR provides higher-resolution data for comparison across time and between patients.
    Virus Res. 2021;306:198604.
    >> Share

    November 2021
  101. LEE TY, Lee H, Kim N, Jeon P, et al
    Comparison of SARS-CoV-2 variant lethality in human angiotensin-converting enzyme 2 transgenic mice.
    Virus Res. 2021;305:198563.
    >> Share

  102. WANG W, Li CP, He M, Li SW, et al
    The dominant strain of SARS-CoV-2 is a mosaicism.
    Virus Res. 2021;305:198553.
    >> Share

  103. BUKIN YS, Bondaryuk AN, Kulakova NV, Balakhonov SV, et al
    Phylogenetic reconstruction of the initial stages of the spread of the SARS-CoV-2 virus in the Eurasian and American continents by analyzing genomic data.
    Virus Res. 2021;305:198551.
    >> Share

  104. TAVAKOLI F, Izadi A, Yavarian J, Sharifi-Zarchi A, et al
    Determination of genetic characterization and circulation pattern of Respiratory Syncytial Virus (RSV) in children with a respiratory infection, Tehran, Iran, during 2018-2019.
    Virus Res. 2021;305:198564.
    >> Share

  105. GUPTA D, Parthasarathy H, Sah V, Tandel D, et al
    Inactivation of SARS-CoV-2 by beta-propiolactone causes aggregation of viral particles and loss of antigenic potential.
    Virus Res. 2021;305:198555.
    >> Share

  106. BOSE T, Pant N, Pinna NK, Bhar S, et al
    Does immune recognition of SARS-CoV2 epitopes vary between different ethnic groups?
    Virus Res. 2021;305:198579.
    >> Share

  107. PRATELLI A, Lucente MS, Mari V, Cordisco M, et al
    A simple pooling salivary test for SARS-CoV-2 diagnosis: A Columbus' egg?
    Virus Res. 2021;305:198575.
    >> Share

    October 2021
  108. FRANCESCHI VB, Ferrareze PAG, Zimerman RA, Cybis GB, et al
    Mutation hotspots and spatiotemporal distribution of SARS-CoV-2 lineages in Brazil, February 2020-2021.
    Virus Res. 2021;304:198532.
    >> Share

  109. HUANG X, Zhang F, Zhu K, Lin W, et al
    dsmCRISPR: Dual synthetic mismatches CRISPR/Cas12a-based detection of SARS-CoV-2 D614G mutation.
    Virus Res. 2021;304:198530.
    >> Share

  110. FORT H
    A very simple model to account for the rapid rise of the alpha variant of SARS-CoV-2 in several countries and the world.
    Virus Res. 2021;304:198531.
    >> Share

  111. VALE FF, Vitor JMB, Marques AT, Azevedo-Pereira JM, et al
    Origin, phylogeny, variability and epitope conservation of SARS-CoV-2 worldwide.
    Virus Res. 2021;304:198526.
    >> Share

  112. ZHAO J, Wang L, Schank M, Dang X, et al
    SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.
    Virus Res. 2021;304:198508.
    >> Share

  113. YAMAYA M, Deng X, Kikuchi A, Sugawara M, et al
    The proton ATPase inhibitor bafilomycin A1 reduces the release of rhinovirus C and cytokines from primary cultures of human nasal epithelial cells.
    Virus Res. 2021;304:198548.
    >> Share

  114. KHAN S, Dobrovolny HM
    A study of the effects of age on the dynamics of RSV in animal models.
    Virus Res. 2021;304:198524.
    >> Share

  115. KANNIAN P, Jayaraman BG, Alamelu S, Lavanya C, et al
    Implications in the quantification of SARS-CoV2 copies in concurrent nasopharyngeal swabs, whole mouth fluid and respiratory droplets.
    Virus Res. 2021;303:198442.
    >> Share

    September 2021
  116. YANG F, Xiao Y, Liu F, Yao H, et al
    Molecular Characterization and Antigenic analysis of reassortant H9N2 subtype avian influenza viruses in Eastern China in 2016.
    Virus Res. 2021 Sep 21:198577. doi: 10.1016/j.virusres.2021.198577.
    >> Share

  117. YE H, Bi Z, Fan W, Song S, et al
    Cellular hnRNPAB interacts with avian influenza viral protein PB2 and inhibits virus replication potentially by restricting PB2 mRNA nuclear export and PB2 protein level.
    Virus Res. 2021 Sep 20:198573. doi: 10.1016/j.virusres.2021.198573.
    >> Share

  118. HAQUE MFU, Bukhari SS, Ejaz R, Zaman FU, et al
    A novel RdRp-based colorimetric RT-LAMP assay for rapid and sensitive detection of SARS-CoV-2 in clinical and sewage samples from Pakistan.
    Virus Res. 2021;302:198484.
    >> Share

  119. GORAICHUK IV, Arefiev V, Stegniy BT, Gerilovych AP, et al
    Zoonotic and Reverse Zoonotic Transmissibility of SARS-CoV-2.
    Virus Res. 2021;302:198473.
    >> Share

  120. EMAM M, Oweda M, Antunes A, El-Hadidi M, et al
    Positive selection as a key player for SARS-CoV-2 pathogenicity: Insights into ORF1ab, S and E genes.
    Virus Res. 2021;302:198472.
    >> Share

  121. STEGMANN KM, Dickmanns A, Gerber S, Nikolova V, et al
    The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models.
    Virus Res. 2021;302:198469.
    >> Share

    August 2021
  122. BURNHAM AJ, Miller JR, Singh I, Billings EA, et al
    Novel isoforms of influenza virus PA-X and PB1-F2 indicated by automatic annotation.
    Virus Res. 2021 Aug 12:198545. doi: 10.1016/j.virusres.2021.198545.
    >> Share

  123. POLICARD M, Jain S, Rego S, Dakshanamurthy S, et al
    Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism.
    Virus Res. 2021;301:198464.
    >> Share

    July 2021
  124. TIAN X, Mo C, Zhou L, Yang Y, et al
    Epitope mapping of severe acute respiratory syndrome-related coronavirus nucleocapsid protein with a rabbit monoclonal antibody.
    Virus Res. 2021;300:198445.
    >> Share

  125. HASSAN SS, Attrish D, Ghosh S, Choudhury PP, et al
    Pathogenic perspective of missense mutations of ORF3a protein of SARS-CoV-2.
    Virus Res. 2021;300:198441.
    >> Share

  126. ABBASI S, Hosseinkhan N, Shafiei Jandaghi NZ, Sadeghi K, et al
    Impact of human rhinoviruses on gene expression in pediatric patients with severe acute respiratory infection.
    Virus Res. 2021;300:198408.
    >> Share

  127. RODRIGUEZ T, Dobrovolny HM
    Quantifying the effect of trypsin and elastase on in vitro SARS-CoV infections.
    Virus Res. 2021;299:198423.
    >> Share

  128. SALEHI-VAZIRI M, Omrani MD, Pouriayevali MH, Fotouhi F, et al
    SARS-CoV-2 presented moderately during two episodes of the infection with lack of antibody responses.
    Virus Res. 2021;299:198421.
    >> Share

  129. ALTABLE M, de la Serna JM
    Protection against COVID-19 in African population: Immunology, genetics, and malaria clues for therapeutic targets.
    Virus Res. 2021;299:198347.
    >> Share

    June 2021
  130. GHOSH N, Saha I, Sharma N, Nandi S, et al
    Genome-wide analysis of 10664 SARS-CoV-2 genomes to identify virus strains in 73 countries based on single nucleotide polymorphism.
    Virus Res. 2021;298:198401.
    >> Share

  131. DOERFLER W
    Viral Vector DNA- and RNA-Based SARS-CoV-2 Vaccines: Possible Integration into the Human Genome Are Adenoviral Genes Expressed in Vector-based Vaccines?
    Virus Res. 2021 Jun 1:198466. doi: 10.1016/j.virusres.2021.198466.
    >> Share

  132. LEI L, Qin H, Luo J, Tan Y, et al
    Construction and immunological evaluation of hepatitis B virus core virus-like particles containing multiple antigenic peptides of respiratory syncytial virus.
    Virus Res. 2021;298:198410.
    >> Share

    May 2021
  133. CARNEIRO DC, Sousa JD, Monteiro-Cunha JP
    The COVID-19 Vaccine Development: A Pandemic Paradigm.
    Virus Res. 2021 May 17:198454. doi: 10.1016/j.virusres.2021.198454.
    >> Share

  134. LEE S, Won D, Kim CK, Ahn J, et al
    Novel indel mutation in the N gene of SARS-CoV-2 clinical samples that were diagnosed positive in a commercial RT-PCR assay.
    Virus Res. 2021;297:198398.
    >> Share

  135. HASAN MM, Das R, Rasheduzzaman M, Hussain MH, et al
    Global and local mutations in Bangladeshi SARS-CoV-2 genomes.
    Virus Res. 2021;297:198390.
    >> Share

  136. RUIZ-GOMEZ X, Vazquez-Perez JA, Flores-Herrera O, Esparza-Perusquia M, et al
    Steady-state persistence of respiratory syncytial virus in a macrophage-like cell line and sequence analysis of the persistent viral genome.
    Virus Res. 2021;297:198367.
    >> Share

    April 2021
  137. FRANCISCO RDS JR, Benites LF, Lamarca AP, de Almeida LGP, et al
    Pervasive transmission of E484K and emergence of VUI-NP13L with evidence of SARS-CoV-2 co-infection events by two different lineages in Rio Grande do Sul, Brazil.
    Virus Res. 2021;296:198345.
    >> Share

  138. MIRANDA RL, Guterres A, de Azeredo Lima CH, Filho PN, et al
    Misinterpretation of viral load in COVID-19 clinical outcomes.
    Virus Res. 2021;296:198340.
    >> Share

  139. LI JY, Wang Q, Liao CH, Qiu Y, et al
    The 442th amino acid residue of the spike protein is critical for the adaptation to bat hosts for SARS-related coronaviruses.
    Virus Res. 2021;295:198307.
    >> Share

  140. SCAGNOLARI C, Pierangeli A, Frasca F, Bitossi C, et al
    Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19).
    Virus Res. 2021;295:198283.
    >> Share

  141. HU Z, Zhao J, Shi L, Hu J, et al
    Identification of the dominant non-neutralizing epitope in the haemagglutinin of H7N9 avian influenza virus.
    Virus Res. 2021;298:198409.
    >> Share

  142. NIYOMDECHA N, Suptawiwat O, Boonarkart C, Thitithanyanont A, et al
    Repurposing of antiparasitic niclosamide to inhibit respiratory syncytial virus (RSV) replication.
    Virus Res. 2021;295:198277.
    >> Share

    March 2021
  143. LANDGRAF G, Desheva YA, Rudenko LG
    Evaluation of influenza A and B cold-adapted reassortant virus reproduction in trivalent live influenza vaccines.
    Virus Res. 2021 Mar 17:198396. doi: 10.1016/j.virusres.2021.198396.
    >> Share

  144. MIYAOKA Y, Kabir H, Hasan A, Yamaguchi M, et al
    Virucidal activity of slightly acidic hypochlorous acid water toward influenza virus and coronavirus with tests simulating practical usage.
    Virus Res. 2021 Mar 8:198383. doi: 10.1016/j.virusres.2021.198383.
    >> Share

  145. SAFARI F, Afarid M, Rastegari B, Borhani-Haghighi A, et al
    CRISPR systems: Novel approaches for detection and combating COVID-19.
    Virus Res. 2021;294:198282.
    >> Share

  146. TAN J, Yuan Y, Xu C, Song C, et al
    A retrospective comparison of drugs against COVID-19.
    Virus Res. 2021;294:198262.
    >> Share

    February 2021
  147. KIM DH, Park BJ, Ahn HS, Go HJ, et al
    Canine interferon lambda 3 expressed using an adenoviral vector effectively induces antiviral activity against canine influenza virus.
    Virus Res. 2021 Feb 16:198342. doi: 10.1016/j.virusres.2021.198342.
    >> Share

  148. RIVERA-BAHENA GB, Marquez-Bandala AH, Lopez-Guerrero DV, Esquivel-Guadarrama FR, et al
    TGF-beta1 signaling inhibit the in vitro apoptotic, infection and stimulatory cell response induced by influenza H1N1 virus infection on A549 cells.
    Virus Res. 2021 Feb 10:198337. doi: 10.1016/j.virusres.2021.198337.
    >> Share

  149. LI B, Xiang G, He J, Li H, et al
    H7N9 influenza virus surveillance in Gansu, China in 2017.
    Virus Res. 2021 Feb 9:198335. doi: 10.1016/j.virusres.2021.198335.
    >> Share

  150. DE CONTO F, Conversano F, Razin SV, Belletti S, et al
    Host-cell dependent role of phosphorylated keratin 8 during influenza A/NWS/33 virus (H1N1) infection in mammalian cells.
    Virus Res. 2021 Feb 5:198333. doi: 10.1016/j.virusres.2021.198333.
    >> Share

  151. AKIYAMA Y, Sakashita K, Arihara M, Kimura Y, et al
    COVID-19 infection in Hokkaido, Japan might depend on the viscosity of atmospheric air.
    Virus Res. 2021;293:198259.
    >> Share

  152. ITO G, Morikawa M, Akimoto S, Masatani T, et al
    Establishment of a safe and convenient assay for detection of HA subtype-specific antibodies with PB2 gene-knockout influenza viruses.
    Virus Res. 2021 Feb 1:198331. doi: 10.1016/j.virusres.2021.198331.
    >> Share

    January 2021
  153. LUBAN J, Sattler RA, Muhlberger E, Graci JD, et al
    The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines.
    Virus Res. 2021;292:198246.
    >> Share

  154. KUMAR R, Rathi H, Haq A, Wimalawansa SJ, et al
    Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19.
    Virus Res. 2021;292:198235.
    >> Share

  155. JOONLASAK K, Batty EM, Kochakarn T, Panthan B, et al
    Genomic surveillance of SARS-CoV-2 in Thailand reveals mixed imported populations, a local lineage expansion and a virus with truncated ORF7a.
    Virus Res. 2021;292:198233.
    >> Share

  156. MALEK A, Hoque A
    Trends of 2019-nCoV in South Asian countries and prediction of the epidemic peaks.
    Virus Res. 2021;292:198230.
    >> Share

  157. CATTEL F, Giordano S, Bertiond C, Lupia T, et al
    Ozone therapy in COVID-19: A narrative review.
    Virus Res. 2021;291:198207.
    >> Share

  158. PIERETTI JC, Rubilar O, Weller RB, Tortella GR, et al
    Nitric oxide (NO) and nanoparticles - Potential small tools for the war against COVID-19 and other human coronavirus infections.
    Virus Res. 2021;291:198202.
    >> Share

  159. CABBAB ILN, Manalo RVM
    Anti-inflammatory drugs and the renin-angiotensin-aldosterone system: Current knowledge and potential effects on early SARS-CoV-2 infection.
    Virus Res. 2021;291:198190.
    >> Share

    December 2020
  160. TAHAGHOGHI-HAJGHORBANI S, Zafari P, Masoumi E, Rajabinejad M, et al
    The role of dysregulated immune responses in COVID-19 pathogenesis.
    Virus Res. 2020;290:198197.
    >> Share

  161. RAJEEV R, Prathiviraj R, Kiran GS, Selvin J, et al
    Zoonotic evolution and implications of microbiome in viral transmission and infection.
    Virus Res. 2020;290:198175.
    >> Share

  162. KILLICK R, Ballard C, Doherty P, Williams G, et al
    Transcription-based drug repurposing for COVID-19.
    Virus Res. 2020;290:198176.
    >> Share

  163. KHARE P, Sahu U, Pandey SC, Samant M, et al
    Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
    Virus Res. 2020;290:198169.
    >> Share

  164. FREIRE-PASPUEL B, Vega-Marino P, Velez A, Cruz M, et al
    "Sample pooling of RNA extracts to speed up SARS-CoV-2 diagnosis using CDC FDA EUA RT-qPCR kit".
    Virus Res. 2020;290:198173.
    >> Share

  165. YAMASAKI Y, Ooka S, Tsuchida T, Nakamura Y, et al
    The peripheral lymphocyte count as a predictor of severe COVID-19 and the effect of treatment with ciclesonide.
    Virus Res. 2020;290:198089.
    >> Share

    November 2020
  166. WEBER S, Ramirez C, Doerfler W
    Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world.
    Virus Res. 2020;289:198170.
    >> Share

  167. GADOTTI AC, de Castro Deus M, Telles JP, Wind R, et al
    IFN-gamma is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection.
    Virus Res. 2020;289:198171.
    >> Share

  168. RANGEL HR, Ortega JT, Maksoud S, Pujol FH, et al
    SARS-CoV-2 host tropism: An in silico analysis of the main cellular factors.
    Virus Res. 2020;289:198154.
    >> Share

  169. ELHABYAN A, Elyaacoub S, Sanad E, Abukhadra A, et al
    The role of host genetics in susceptibility to severe viral infections in humans and insights into host genetics of severe COVID-19: A systematic review.
    Virus Res. 2020;289:198163.
    >> Share

  170. WANG X, Zheng J, Guo L, Yao H, et al
    Fecal viral shedding in COVID-19 patients: Clinical significance, viral load dynamics and survival analysis.
    Virus Res. 2020;289:198147.
    >> Share

  171. MARDANI R, Alamdary A, Mousavi Nasab SD, Gholami R, et al
    Association of vitamin D with the modulation of the disease severity in COVID-19.
    Virus Res. 2020;289:198148.
    >> Share

  172. CHOUDHARY S, Silakari O
    Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19.
    Virus Res. 2020;289:198146.
    >> Share

    October 2020
  173. ZHOU Y, Wu X, Yan D, Chen C, et al
    V292I Mutation in PB2 Polymerase Induces Increased Effects of E627K on Influenza H7N9 Virus Replication in Cells.
    Virus Res. 2020 Oct 16:198186. doi: 10.1016/j.virusres.2020.198186.
    >> Share

  174. YOKOYAMA Y, Briasoulis A, Takagi H, Kuno T, et al
    Effect of remdesivir on patients with COVID-19: A network meta-analysis of randomized control trials.
    Virus Res. 2020;288:198137.
    >> Share

  175. ALI Z, Aman R, Mahas A, Rao GS, et al
    iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2.
    Virus Res. 2020;288:198129.
    >> Share

  176. DUTTA R, Buragohain L, Borah P
    Analysis of codon usage of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) and its adaptability in dog.
    Virus Res. 2020;288:198113.
    >> Share

  177. MOHAMMAD T, Shamsi A, Anwar S, Umair M, et al
    Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy.
    Virus Res. 2020;288:198102.
    >> Share

  178. SITARAS I, Spackman E, de Jong MCM, Parris DJ, et al
    Selection and Antigenic Characterization of Immune-Escape Mutants of H7N2 Low Pathogenic Avian Influenza Virus Using Homologous Polyclonal Sera.
    Virus Res. 2020 Oct 9:198188. doi: 10.1016/j.virusres.2020.198188.
    >> Share

    August 2020
  179. SAMRAT SK, Tharappel AM, Li Z, Li H, et al
    Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development.
    Virus Res. 2020 Aug 23:198141. doi: 10.1016/j.virusres.2020.198141.
    >> Share

  180. KAUR SP, Gupta V
    COVID-19 Vaccine: A comprehensive status report.
    Virus Res. 2020 Aug 12:198114. doi: 10.1016/j.virusres.2020.198114.
    >> Share

    July 2020
  181. LIN L, Ting S, Yufei H, Wendong L, et al
    Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
    Virus Res. 2020 Jul 1:198082. doi: 10.1016/j.virusres.2020.198082.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016